Originally posted by Xi Wang
View Post
-
Yeah, that too. But to stay on topic, 100 HiSeq 2000s will be in HK. This will make HK the sequencing capital of the world!
-
-
Do we really need 60x coverage for genome sequencing???Originally posted by Chipper View Post
Comment
-
Who in HK is buying 100 HiSeq instruments? I did read the press release that BGI are buying 128 HiSeqs but they are based in Shenzhen, which is in mainland China?Originally posted by ymc View PostYeah, that too. But to stay on topic, 100 HiSeq 2000s will be in HK. This will make HK the sequencing capital of the world!Comment
-
Oh, I've re-read the press release and I see that they are installing the machines in Hong Kong Science Park:
Comment
-
Yeah i noticed the discrepancy as well?Originally posted by ymc View Post
is it some vandalism to put in false numbers?
I think the source url should be put in the spreadsheet as referenceComment
-
I can be added as a HYPERLINK to the number, like this:Originally posted by KevinLam View Post
=HYPERLINK ( "http://www3.appliedbiosystems.com/cms/groups/global_marketing_group/documents/generaldocuments/cms_078637.pdf" ; 100)
Then it will be clickable when seen in a website:
CheersComment
-
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...07-31-2026, 11:01 AM -
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM
Comment